369 related articles for article (PubMed ID: 28411194)
1. Systematic characterization of A-to-I RNA editing hotspots in microRNAs across human cancers.
Wang Y; Xu X; Yu S; Jeong KJ; Zhou Z; Han L; Tsang YH; Li J; Chen H; Mangala LS; Yuan Y; Eterovic AK; Lu Y; Sood AK; Scott KL; Mills GB; Liang H
Genome Res; 2017 Jul; 27(7):1112-1125. PubMed ID: 28411194
[TBL] [Abstract][Full Text] [Related]
2. Attenuated adenosine-to-inosine editing of microRNA-376a* promotes invasiveness of glioblastoma cells.
Choudhury Y; Tay FC; Lam DH; Sandanaraj E; Tang C; Ang BT; Wang S
J Clin Invest; 2012 Nov; 122(11):4059-76. PubMed ID: 23093778
[TBL] [Abstract][Full Text] [Related]
3. ADAR1-mediated RNA editing is a novel oncogenic process in thyroid cancer and regulates miR-200 activity.
Ramírez-Moya J; Baker AR; Slack FJ; Santisteban P
Oncogene; 2020 Apr; 39(18):3738-3753. PubMed ID: 32157211
[TBL] [Abstract][Full Text] [Related]
4. ADAR2/miR-589-3p axis controls glioblastoma cell migration/invasion.
Cesarini V; Silvestris DA; Tassinari V; Tomaselli S; Alon S; Eisenberg E; Locatelli F; Gallo A
Nucleic Acids Res; 2018 Feb; 46(4):2045-2059. PubMed ID: 29267965
[TBL] [Abstract][Full Text] [Related]
5. GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification.
Chung VY; Tan TZ; Tan M; Wong MK; Kuay KT; Yang Z; Ye J; Muller J; Koh CM; Guccione E; Thiery JP; Huang RY
Sci Rep; 2016 Feb; 6():19943. PubMed ID: 26887977
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma.
Kurashige J; Kamohara H; Watanabe M; Hiyoshi Y; Iwatsuki M; Tanaka Y; Kinoshita K; Saito S; Baba Y; Baba H
Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S656-64. PubMed ID: 22311119
[TBL] [Abstract][Full Text] [Related]
7. CircZFR serves as a prognostic marker to promote bladder cancer progression by regulating miR-377/ZEB2 signaling.
Zhang WY; Liu QH; Wang TJ; Zhao J; Cheng XH; Wang JS
Biosci Rep; 2019 Dec; 39(12):. PubMed ID: 31746333
[TBL] [Abstract][Full Text] [Related]
8. Clinical Relevance of Noncoding Adenosine-to-Inosine RNA Editing in Multiple Human Cancers.
Gu T; Fu AQ; Bolt MJ; White KP
JCO Clin Cancer Inform; 2019 Jun; 3():1-8. PubMed ID: 31162949
[TBL] [Abstract][Full Text] [Related]
9. Competing Endogenous RNA of Snail and Zeb1 UTR in Therapeutic Resistance of Colorectal Cancer.
Kim NH; Song SH; Choi YH; Hwang KH; Yun JS; Song H; Cha SY; Cho SB; Lee I; Kim HS; Yook JI
Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502497
[TBL] [Abstract][Full Text] [Related]
10. The Cancer Editome Atlas: A Resource for Exploratory Analysis of the Adenosine-to-Inosine RNA Editome in Cancer.
Lin CH; Chen SC
Cancer Res; 2019 Jun; 79(11):3001-3006. PubMed ID: 31015229
[TBL] [Abstract][Full Text] [Related]
11. The long non-coding RNA MIAT regulates zinc finger E-box binding homeobox 1 expression by sponging miR-150 and promoteing cell invasion in non-small-cell lung cancer.
Zhang HY; Zheng FS; Yang W; Lu JB
Gene; 2017 Oct; 633():61-65. PubMed ID: 28843520
[TBL] [Abstract][Full Text] [Related]
12. A-to-I editing of microRNAs in the mammalian brain increases during development.
Ekdahl Y; Farahani HS; Behm M; Lagergren J; Öhman M
Genome Res; 2012 Aug; 22(8):1477-87. PubMed ID: 22645261
[TBL] [Abstract][Full Text] [Related]
13. The Genomic Landscape and Clinical Relevance of A-to-I RNA Editing in Human Cancers.
Han L; Diao L; Yu S; Xu X; Li J; Zhang R; Yang Y; Werner HMJ; Eterovic AK; Yuan Y; Li J; Nair N; Minelli R; Tsang YH; Cheung LWT; Jeong KJ; Roszik J; Ju Z; Woodman SE; Lu Y; Scott KL; Li JB; Mills GB; Liang H
Cancer Cell; 2015 Oct; 28(4):515-528. PubMed ID: 26439496
[TBL] [Abstract][Full Text] [Related]
14. Redirection of silencing targets by adenosine-to-inosine editing of miRNAs.
Kawahara Y; Zinshteyn B; Sethupathy P; Iizasa H; Hatzigeorgiou AG; Nishikura K
Science; 2007 Feb; 315(5815):1137-40. PubMed ID: 17322061
[TBL] [Abstract][Full Text] [Related]
15. Zinc finger E-box-binding homeobox 2 (ZEB2) regulated by miR-200b contributes to multi-drug resistance of small cell lung cancer.
Fang S; Zeng X; Zhu W; Tang R; Chao Y; Guo L
Exp Mol Pathol; 2014 Jun; 96(3):438-44. PubMed ID: 24769353
[TBL] [Abstract][Full Text] [Related]
16. The adaptive potential of RNA editing-mediated miRNA-retargeting in cancer.
Tassinari V; Cesarini V; Silvestris DA; Gallo A
Biochim Biophys Acta Gene Regul Mech; 2019 Mar; 1862(3):291-300. PubMed ID: 30605729
[TBL] [Abstract][Full Text] [Related]
17. Perturbation of biogenesis and targeting of Epstein-Barr virus-encoded miR-BART3 microRNA by adenosine-to-inosine editing.
Lei T; Yuen KS; Tsao SW; Chen H; Kok KH; Jin DY
J Gen Virol; 2013 Dec; 94(Pt 12):2739-2744. PubMed ID: 24045110
[TBL] [Abstract][Full Text] [Related]
18. MiR-200 can repress breast cancer metastasis through ZEB1-independent but moesin-dependent pathways.
Li X; Roslan S; Johnstone CN; Wright JA; Bracken CP; Anderson M; Bert AG; Selth LA; Anderson RL; Goodall GJ; Gregory PA; Khew-Goodall Y
Oncogene; 2014 Jul; 33(31):4077-88. PubMed ID: 24037528
[TBL] [Abstract][Full Text] [Related]
19. The effects of Micro-429 on inhibition of cervical cancer cells through targeting ZEB1 and CRKL.
Wang Y; Dong X; Hu B; Wang XJ; Wang Q; Wang WL
Biomed Pharmacother; 2016 May; 80():311-321. PubMed ID: 27133071
[TBL] [Abstract][Full Text] [Related]
20. When MicroRNAs Meet RNA Editing in Cancer: A Nucleotide Change Can Make a Difference.
Wang Y; Liang H
Bioessays; 2018 Feb; 40(2):. PubMed ID: 29280160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
